323 related articles for article (PubMed ID: 11471123)
1. Managing the anemia of prematurity: red blood cell transfusions versus recombinant erythropoietin.
Strauss RG
Transfus Med Rev; 2001 Jul; 15(3):213-23. PubMed ID: 11471123
[TBL] [Abstract][Full Text] [Related]
2. Current controversies in the management of the anemia of prematurity.
Bishara N; Ohls RK
Semin Perinatol; 2009 Feb; 33(1):29-34. PubMed ID: 19167579
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human erythropoietin in the treatment of anemia of prematurity.
Chen JY; Wu TS; Chanlai SP
Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
[TBL] [Abstract][Full Text] [Related]
5. [Usefulness of erythropoietin in the treatment of anemia of prematurity. Influence of birth weight].
Carbonell Estrany X; Figueras Aloy J; Pérez Fernández JM; Fernández López A; González Luis G; Salvía Roiges MD
An Esp Pediatr; 1999 Sep; 51(3):281-6. PubMed ID: 10575752
[TBL] [Abstract][Full Text] [Related]
6. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.
Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G
N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study.
Meyer MP; Meyer JH; Commerford A; Hann FM; Sive AA; Moller G; Jacobs P; Malan AF
Pediatrics; 1994 Jun; 93(6 Pt 1):918-23. PubMed ID: 8190577
[TBL] [Abstract][Full Text] [Related]
8. Controversies in the management of the anemia of prematurity using single-donor red blood cell transfusions and/or recombinant human erythropoietin.
Strauss RG
Transfus Med Rev; 2006 Jan; 20(1):34-44. PubMed ID: 16373186
[TBL] [Abstract][Full Text] [Related]
9. Anemia of prematurity.
Salsbury DC
Neonatal Netw; 2001 Aug; 20(5):13-20. PubMed ID: 12144218
[TBL] [Abstract][Full Text] [Related]
10. Pilot study comparing recombinant erythropoietin alone with erythropoietin plus recombinant granulocyte-macrophage colony-stimulating factor for treatment of the anemia of prematurity.
Christensen RD; Hunter DD; Ohls RK
J Perinatol; 1994; 14(2):110-3. PubMed ID: 8014692
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human erythropoietin in anemia of prematurity.
Whitehall JS; Patole SK; Campbell P
Indian Pediatr; 1999 Jan; 36(1):17-27. PubMed ID: 10709119
[TBL] [Abstract][Full Text] [Related]
12. Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity.
Ohls RK; Christensen RD
J Pediatr; 1991 Nov; 119(5):781-8. PubMed ID: 1941387
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants.
Boedy RF; Mathew OP
Pediatrics; 2005 Oct; 116(4):1048-9; author reply 1049-50. PubMed ID: 16199722
[No Abstract] [Full Text] [Related]
14. Anemia of prematurity: the prospects for avoiding blood transfusions by treatment with recombinant human erythropoietin.
Dallman PR
Adv Pediatr; 1993; 40():385-403. PubMed ID: 8249712
[No Abstract] [Full Text] [Related]
15. [Anemia of prematurity: risk factors influencing red cell transfusions].
Zuppa AA; Mazzotta M; Maragliano G; Girlando P; Florio MG; Tortorolo G
Minerva Pediatr; 1995; 47(1-2):13-8. PubMed ID: 7791703
[TBL] [Abstract][Full Text] [Related]
16. Recombinant erythropoietin for the anemia of prematurity: still a promise, not a panacea.
Strauss RG
J Pediatr; 1997 Nov; 131(5):653-5. PubMed ID: 9403639
[No Abstract] [Full Text] [Related]
17. [Criteria for diagnosis and therapy of hyporegeneratory anemia in premature newborns below 33 week of gestation and body weight below 1500 grams].
Pramatarova T; Vakrilova L; Slŭncheva B; Iarŭkova N; Kalaĭdzhieva M; Emilova Z; Shishkova R; Popivanova A; Zhekova N
Akush Ginekol (Sofiia); 2007; 46 Suppl 1():63-6. PubMed ID: 18173017
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial to develop criteria for administering erythrocyte transfusions to anemic preterm infants 1 to 3 months of age.
Ross MP; Christensen RD; Rothstein G; Koenig JM; Simmons MA; Noble NA; Kimura RE
J Perinatol; 1989 Sep; 9(3):246-53. PubMed ID: 2681578
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human erythropoietin therapy for treatment of anemia of prematurity in very low birth weight infants: a randomized, double-blind, placebo-controlled trial.
Kumar P; Shankaran S; Krishnan RG
J Perinatol; 1998; 18(3):173-7. PubMed ID: 9659643
[TBL] [Abstract][Full Text] [Related]
20. The role of high-dose oral iron supplementation during erythropoietin therapy for anemia of prematurity.
Bader D; Kugelman A; Maor-Rogin N; Weinger-Abend M; Hershkowitz S; Tamir A; Lanir A; Attias D; Barak M
J Perinatol; 2001 Jun; 21(4):215-20. PubMed ID: 11533837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
